The global apoptosis assays market was valued at US$ 4.6 Bn in 2023 and is projected to reach US$ 11.3 Bn by 2034, expanding at a robust CAGR of 8.5% from 2024 to 2034. The market’s strong growth trajectory reflects increasing research into programmed cell death mechanisms, rising prevalence of chronic diseases, and the introduction of advanced assay kits and radionuclide tracers.  ...